Regional heterogeneity in expression of the sphingosine-1-phosphate pathway in the female rat lower urinary tract

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 5, 2009, Pages 576.e1-576.e7

  Sandhu, Katherine S ^a   Chua, Rowena G ^a   Zhang, Xinhua ^a   Kanika, Nirmala Devi ^a   Collins, Sarah A ^a   Mikhail, Magdy ^a   Melman, Arnold ^a   DiSanto, Michael E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

G protein coupled receptor; overactive bladder; rho kinase; smooth muscle; sphingosine 1 phosphate

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; REGULATOR PROTEIN; RHO KINASE; SPHINGOSINE 1 PHOSPHATE;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER FUNCTION; BLADDER MUSCLE; BLURRED VISION; CONSTIPATION; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; GENETIC HETEROGENEITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOWER URINARY TRACT SYMPTOM; NONHUMAN; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE TONE; STUDENT T TEST; XEROSTOMIA;

EID: 64249083208     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.12.007     Document Type: Article

References (23)

1. Colli E., Digesu G.A., and Olivieri L. Overactive bladder treatments in early phase clinical trials. Expert Opin Investig Drugs 16 (2007) 999-1007
2. Hu T.W., and Wagner T.H. Health-related consequences of overactive bladder: an economic perspective. BJU Int 96 Suppl 1 (2005) 43-45
3. Andersson K.E. Detrusor contraction-focus on muscarinic receptors. Scand J Urol Nephrol Suppl 215 (2004) 54-57
4. Macdiarmid S.A. Maximizing anticholinergic therapy for overactive bladder: has the ceiling been reached?. BJU Int 99 Suppl 3 (2007) 8-12
5. Sabbadini R.A. Targeting sphingosine-1-phosphate for cancer therapy. Br J Cancer 95 (2006) 1131-1135
6. Alvarez S.E., Milstien S., and Spiegel S. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab 18 (2007) 300-307
7. Hanel P., Andreani P., and Graler M.H. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 21 (2007) 1202-1209
8. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 5 (2005) 560-570
9. Igarashi J., Bernier S.G., and Michel T. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase: differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem 276 (2001) 12420-12426
10. Ishii I., Ye X., Friedman B., et al. Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3. J Biol Chem 277 (2002) 25152-25159
11. Hu W., Mahavadi S., Huang J., Li F., and Murthy K.S. Characterization of S1P1 and S1P2 receptor function in smooth muscle by receptor silencing and receptor protection. Am J Physiol Gastrointest Liver Physiol 291 (2006) G605-G610
12. Salomone S., Yoshimura S., Reuter U., et al. S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur J Pharmacol 469 (2003) 125-134
13. Watterson K.R., Berg K.M., Kapitonov D., et al. Sphingosine-1-phosphate and the immunosuppressant, FTY720-phosphate, regulate detrusor muscle tone. FASEB J 21 (2007) 2818-2828
14. Ancellin N., and Hla T. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J Biol Chem 274 (1999) 18997-19002
15. Hedemann J., Fetscher C., and Michel M.C. Comparison of noradrenaline and lysosphingolipid-induced vasoconstriction in mouse and rat small mesenteric arteries. Auton Autacoid Pharmacol 24 (2004) 77-85
16. Andreani P., and Graler M.H. Comparative quantification of sphingolipids and analogs in biological samples by high-performance liquid chromatography after chloroform extraction. Anal Biochem 358 (2006) 239-246
17. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
18. Vizzard M.A., Erdman S.L., Forstermann U., and de Groat W.C. Differential distribution of nitric oxide synthase in neural pathways to the urogenital organs (urethra, penis, urinary bladder) of the rat. Brain Res 646 (1994) 279-291
19. Mamas M.A., Reynard J.M., and Brading A.F. Nitric oxide and the lower urinary tract: current concepts, future prospects. Urology 61 (2003) 1079-1085
20. Huwiler A., and Zangemeister-Wittke U. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy. Crit Rev Oncol Hematol 63 (2007) 150-159
21. Hemmings D.G., Xu Y., and Davidge S.T. Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. Br J Pharmacol 143 (2004) 276-284
22. Hait N.C., Oskeritzian C.A., Paugh S.W., Milstien S., and Spiegel S. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 1758 (2006) 2016-2026
23. Sukocheva O.A., Wang L., Albanese N., Pitson S.M., Vadas M.A., and Xia P. Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Mol Endocrinol 17 (2003) 2002-2012